Fieldview Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,050
Closed -$779K 578
2026
Q1
$779K Sell
8,050
-30,194
-79% -$3.1M 0.23% 141
2025
Q4
$4.06M Buy
38,244
+2,347
+7% +$272K 0.69% 28
2025
Q3
$4.56M Buy
35,897
+8,871
+33% +$1.06M 0.75% 28
2025
Q2
$3.31M Sell
27,026
-18,566
-41% -$2.12M 0.5% 74
2025
Q1
$4.62M Sell
45,592
-2,119
-4% -$207K 0.65% 39
2024
Q4
$4.41M Buy
+47,711
New +$4.68M 0.68% 36

Other funds holding EHC

Fieldview Capital Management's EHC Position: Q2 2026 in Review

Fieldview Capital Management sold out of Encompass Health (EHC) in Q2 2026, closing a stake of 8,050 shares — an estimated $779K sold.

Fieldview Capital Management first reported a position in EHC in Q4 2024 and held it in 6 quarters. The position peaked at $4.62M in Q1 2025. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Fieldview Capital Management reported no remaining Encompass Health position as of Q2 2026 after selling out during the quarter.
  • Fieldview Capital Management sold 8,050 Encompass Health shares in Q2 2026, an estimated $779K.
  • Fieldview Capital Management first reported a position in Encompass Health in Q4 2024 and held it in 6 quarters.
  • Fieldview Capital Management's Encompass Health position peaked at $4.62M in Q1 2025.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Fieldview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.